Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlotte Behning

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
The British Journal of Ophthalmology|March 31, 2022
Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration - a MACUSTAR study reportJan Henrik Terheyden, Susanne G Pondorfer, Charlotte Behning, et al.
Scientific Reports|October 9, 2025
Patient-reported vision impairment in low luminance relates to visual function in age-related macular degeneration: A MACUSTAR study reportJan Henrik Terheyden, Charlotte Behning, Hannah M P Dunbar, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 30, 2024
Associations of Urine and Plasma Metabolites With Kidney Failure and Death in a Chronic Kidney Disease CohortInga Steinbrenner, Ulla T Schultheiss, Helena Bächle, et al.
JAMA Ophthalmology|June 23, 2022
Repeatability and Discriminatory Power of Chart-Based Visual Function Tests in Individuals With Age-Related Macular Degeneration: A MACUSTAR Study ReportHannah M P Dunbar, Charlotte Behning, Amina Abdirahman, et al.
Translational Vision Science & Technology|September 26, 2025
Associations Between Structural Phenotype and Polygenic Risk Scores in Intermediate Age-Related Macular Degeneration - A MACUSTAR ReportLukas Schloesser, Jan H Terheyden, Charlotte Behning, et al.
Translational Vision Science & Technology|July 21, 2023
Test-Retest Variability and Discriminatory Power of Measurements From Microperimetry and Dark Adaptation Assessment in People With Intermediate Age-Related Macular Degeneration - A MACUSTAR Study ReportBethany E Higgins, Giovanni Montesano, Hannah M P Dunbar, et al.
BMC Medical Research Methodology|March 18, 2021
Challenges, facilitators and barriers to screening study participants in early disease stages-experience from the MACUSTAR studyJan Henrik Terheyden, Charlotte Behning, Anna Lüning, et al.
Eye (London, England)|February 5, 2025
Validating candidate endpoints for intermediate age-related macular degeneration trials in a multi-centre setting-lessons from the MACUSTAR studyJan Henrik Terheyden, Hannah M P Dunbar, Steffen Schmitz-Valckenberg, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|February 3, 2025
The Spectrum of Functional, Structural, and Patient-Reported Outcomes in Intermediate Age-Related Macular Degeneration: A MACUSTAR Study ReportJan Henrik Terheyden, Frank G Holz, Charlotte Behning, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 15, 2025
Risk of Epilepsy and Factors Associated With Time to Seizure Remission in Anti-LGI1 Encephalitis: Long-Term Outcome in 236 PatientsTobias Baumgartner, Moritz Freyberg, Lucia Campetella, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
The British Journal of Ophthalmology|March 31, 2022
Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration - a MACUSTAR study reportJan Henrik Terheyden, Susanne G Pondorfer, Charlotte Behning, et al.
Scientific Reports|October 9, 2025
Patient-reported vision impairment in low luminance relates to visual function in age-related macular degeneration: A MACUSTAR study reportJan Henrik Terheyden, Charlotte Behning, Hannah M P Dunbar, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 30, 2024
Associations of Urine and Plasma Metabolites With Kidney Failure and Death in a Chronic Kidney Disease CohortInga Steinbrenner, Ulla T Schultheiss, Helena Bächle, et al.
JAMA Ophthalmology|June 23, 2022
Repeatability and Discriminatory Power of Chart-Based Visual Function Tests in Individuals With Age-Related Macular Degeneration: A MACUSTAR Study ReportHannah M P Dunbar, Charlotte Behning, Amina Abdirahman, et al.
Translational Vision Science & Technology|September 26, 2025
Associations Between Structural Phenotype and Polygenic Risk Scores in Intermediate Age-Related Macular Degeneration - A MACUSTAR ReportLukas Schloesser, Jan H Terheyden, Charlotte Behning, et al.
Translational Vision Science & Technology|July 21, 2023
Test-Retest Variability and Discriminatory Power of Measurements From Microperimetry and Dark Adaptation Assessment in People With Intermediate Age-Related Macular Degeneration - A MACUSTAR Study ReportBethany E Higgins, Giovanni Montesano, Hannah M P Dunbar, et al.
BMC Medical Research Methodology|March 18, 2021
Challenges, facilitators and barriers to screening study participants in early disease stages-experience from the MACUSTAR studyJan Henrik Terheyden, Charlotte Behning, Anna Lüning, et al.
Eye (London, England)|February 5, 2025
Validating candidate endpoints for intermediate age-related macular degeneration trials in a multi-centre setting-lessons from the MACUSTAR studyJan Henrik Terheyden, Hannah M P Dunbar, Steffen Schmitz-Valckenberg, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|February 3, 2025
The Spectrum of Functional, Structural, and Patient-Reported Outcomes in Intermediate Age-Related Macular Degeneration: A MACUSTAR Study ReportJan Henrik Terheyden, Frank G Holz, Charlotte Behning, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 15, 2025
Risk of Epilepsy and Factors Associated With Time to Seizure Remission in Anti-LGI1 Encephalitis: Long-Term Outcome in 236 PatientsTobias Baumgartner, Moritz Freyberg, Lucia Campetella, et al.
Pageof 6